<DOC>
	<DOCNO>NCT01338610</DOCNO>
	<brief_summary>The purpose study evaluate efficacy ESBA105 vehicle reduce ocular symptom dry eye disease , measure mean global Visual Analog Scale ( VAS ) discomfort score .</brief_summary>
	<brief_title>ESBA105 Patients With Severe Dry Eye</brief_title>
	<detailed_description>Following Run-In , patient qualify treatment randomize 2:1 receive ESBA105 ( experimental group ) Vehicle ( control group ) 4 week . Patients qualify treatment ( base global VAS discomfort score ) , discontinue study .</detailed_description>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Ongoing physician diagnosis dry eye least 6 month . Use artificial tear , gel , lubricant , rewetting drop regular basis . Experience persistent ocular discomfort . Other protocoldefined inclusion criterion may apply . Contact lens wearer . Severe Sjogren 's Syndrome . History corneal surgery include refractive surgery . Intraocular surgery within 6 month Visit 1 . Intraocular periocular injection within 6 month Visit 1 . Lid function abnormality . Use steroid , tetracycline , doxycycline , etc. , within 30 day Visit 1 . Any acute infectious noninfectious ocular condition anterior posterior segment either eye within 30 day Visit 1 . Diseases/conditions ocular surface associate clinically significant scarring/destruction conjunctiva/cornea . Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Ocular discomfort</keyword>
</DOC>